GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.11G163300	P02929		1	9.44207518427327e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P08188	1H-1,2,4-Triazole-1-ethanol, alpha,alpha-bis(4-fluorophenyl)-	1	4.98101771904721e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P10900	Cabozantinib	1	3.84919252075159e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P14084	2-(2'-Propenyl)-delta-1-piperideine	1	3.15963479644625e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P15259	6-Ethyl-3-hydroxy-2-methyl-4-pyrone	1	9.61835246613272e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P15816	Cilastatin	1	2.40392359104347e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P20272	Aristoloterpenate II	1	9.74847135919296e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P21187	1-Fluorocyclohexadiene-cis,cis-1,2-diol	1	2.32266693835297e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P22671	Kodaistatin C	1	1.57662088154193e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P22895	FD 212	1	1.64779989721603e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P25842	Birabresib	1	3.07637946825704e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P29651	Destruxin E diol	1	8.71209074602116e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P29716	Matteuorienate C	1	8.16132325073514e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P29880	Mukurozioside IIa	1	1.46665526641492e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P30912		1	6.25945471793324e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P31583	Rhusemialin A	1	4.73007056633513e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P32646	Antibiotic DC 11A2	1	5.93891530001921e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P34021		1	1.07715863720112e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P34124		1	3.88402352881456e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P35821	[(2R,3S,4R,5R,6R)-2-(Hydroxymethyl)-4,5-bis[[(3R)-3-hydroxytetradecanoyl]amino]-6-phosphonooxyoxan-3-yl] dihydrogen phosphate	1	8.82488785381803e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P35961	CL(8:0/8:0/8:0/8:0)	1	4.80013606497798e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P36283	Isopropyl dodecylfluorophosphonate	1	1.13025480484279e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P36912	Rhodojaponin IV	1	4.5245408283756e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P37072	4,4'-Diapophytofluene	1	3.32774892752834e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P37330	5,6-Epoxyoctadeca-7,9-diynoic acid	1	5.98266767567869e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P37350	Nobiloside	1	2.02361007696756e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P37394	Bryostatin 10	1	2.56853273971242e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P38302	(25S)-3-O-(beta-D-xylopyranosyl)-cholest-4-ene-3beta,6beta,8,15alpha,16beta,26-hexaol	1	3.5870612848829e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P38351	Voacamine	1	1.53319352222654e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P41007	Loperamide oxide	1	4.14997136018171e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P41962	Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4(NeuGcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)	1	4.44294040745892e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P42723	CJ 15208	1	1.91876083794797e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P44498	PA(18:4(6Z,9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)-OH(19S))	1	1.31412621598652e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P44506		1	4.25287397197353e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P49216	9,10,12,13,15,16-hexahydroxyoctadecanoic acid	1	7.37887479317723e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P49218	Embutramide	1	3.94326088935069e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P49634	LysoPC(17:0/0:0)	1	5.79600038102566e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P51725	Paliurine E	1	6.54155087046494e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.11G163300	P53707	3beta,11-Dihydroxy-5beta,6beta-epoxy-9,11-secogorgostan-9-one	1	3.32705990975371e-11	overlap	1e-10	<	Wm82.a2.v1